Pancreatic Cancer Research

ResearcherUniversity of AntwerpActive in the last 2 years

Johannes Bogers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9107-132X; OpenAlex author ID A5022514237. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Nucleoside analogue labelling to study the cell cycle of pancreatic cancer xenografts in the chicken embryo model Last author DOI 10.1101/2025.09.09.675135↗
  2. CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma. Last author DOI 10.3390/cancers17243902↗
  3. Hyperthermia Enhances Efficacy of Chemotherapeutic Agents in Pancreatic Cancer Cell Lines. Last author DOI 10.3390/biom12050651↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robin Colenbier · 2 shared papers, 2022–2025 · strength 0.52
  2. Luigi Brancato · 2 shared papers, 2022–2025 · strength 0.43
  3. Susan Elaine Bates · 1 shared paper, 2025 · strength 0.28
  4. Eric Van Cutsem · 1 shared paper, 2025 · strength 0.28
  5. Costanza E. Maurici · 1 shared paper, 2022 · strength 0.15
  6. Elisa Giovannetti · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.